Unregistered/unlicensed medical products that have not undergone evaluation and/or approval by the National or Regional Regulatory Authority for the market in which they are marketed/distributed or used, subject to allowed conditions under national or regional regulation and legislation.

Parallel imports in the pharmaceutical industry have existed for more than 40 years. Today, the total market for parallel imports of medicine is estimated at EUR 5.5 billion. Germany is the largest market for parallel trade of medicine and is more than half of the total market.

The main outcome of that type is the continuous flow of the medicine to that region, if the agent doesn’t have enough stock or if it’s not registered at all in that country, with specific ministry of health requirements and regulation of doing so. 

We, Sahara Pharmaceutical, provide the best quality NR medicine with competitive prices applying UAE MOH regulations from different parts of the world, to match our customers’ needs.